Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide Long-term Safety in Pediatric Partial-onset Seizures
CTR20170054Phase 3Completed
- Sponsor
- UCB
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in epilepsy, sponsored by UCB. Started May 2018; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20170054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170054.